Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism

European Journal of Immunology

Volumn 28, Issue 10, 1998, Pages 3110-3119

  Bachmann, Martin F ^a   Speiser, Daniel E ^b   Zakarian, Arsen ^b   Ohashi, Pamela S ^b  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Altered peptide ligand; Antagonist; TCR triggering

Indexed keywords

CD8 ANTIGEN; LIGAND; PARTIAL AGONIST; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CELL DIVISION; CELLS, CULTURED; DOWN-REGULATION; EPITOPES, T-LYMPHOCYTE; GLYCOPROTEINS; LIGANDS; MACROPHAGES; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0031682701     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199810)28:10<3110::AID-IMMU3110>3.0.CO;2-5     Document Type: Article

References (48)

1. Lenschow, D. J., Walunas, T. L. and Bluestone, J., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 259-274.
2. Cantrell, D., T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996. 14: 259-274.
3. Dustin, M. L. and Springer, T. A., Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 1991. 9: 27-66.
4. Chan, A. C., Desai, D. M. and Weiss, A., The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 1994. 12: 555-592.
5. Yoon, S. T., Dianzani, U., Bottomly, K. and Janeway, C. A., Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1994. 1: 563-569.
6. Janeway, C. A., Medhzhitov, R., Pfeiffer, C., Tao, X. and Bottomly, K., Altered peptide ligands: Conformational changes in the TCR. The Immunologist 1995. 3: 41-44.
7. Kaye, J., Porcelli, S., Tite, J., Jones, B. and Janeway, J., Both a monoclonal antibody and antisera specific for determinants unique to individual cloned T helper cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med. 1983. 158: 836-856.
8. Meuer, S. C., Hodgdon, J. C., Hussey, R. E., Protentis, J. P., Schlossman, S. F. and Reinherz, E. L., Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J. Exp. Med. 1983. 158: 988-993.
9. Abastado, J.-P., Lone, Y.-C., Casrouge, A., Boulot, G. and Kourilsky, P., Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 1995. 182: 439-447.
10. Rhode, P. R., Burkhardt, M., Jiao, J.-A., Siddiqui, A. H., Hunag, G. P. and Wong, H. C., Single-chain MHC class II molecules induce T cell activation and apoptosis. J. Immunol. 1996. 1657: 4885-4891.
11. Reich, Z., Boniface, J. J., Lyons, D. S., Borochov, N., Wachtel, E. J. and Davis, M. M., Ligand-specific oligomerization of T cell receptor molecules. Nature 1997. 387: 617-620.
12. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C., Structure of the complex between human T cell receptor, viral peptide and HLA-2. Nature 1996. 384: 134-141.
13. Fields, B. A., Ober, B., Malchiodi, E. L., Lebedeva, M. I., Braden, B. C., Ysern, X. Y., Kim, J.-K., Shao, X., Ward, E. S. and Mariuzza, R. A., Crystal Structure of the V-alpha domain of a T cell antigen receptor. Science 1995. 270: 1821-1824.
14. Bachmann, M. F., Salzmann, M., Oxenius, A. and Ohashi, P. S., Formation of TCR dimers/trimers as a crucial step for T cell activation. Eur. J. Immunol. 1998. 28: 2571-2579.
15. Grossman, Z. and Paul, W. E., Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA 1992. 89: 10365-10369.
16. Evavold, B. D. and Allen, P. M., Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991. 252: 1308-1310.
17. Evavold, B. D., Sloan-Lancaster, J. and Allen, P. M., Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 1993. 14: 602-609.
18. Höllsberg, P., Weber, W. E. J., Dangond, F., Batra, V., Sette, A. and Hafler, D. A., Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 1995. 92: 4036-4040.
19. Brossait, P. and Bevan, M. J., Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 1996. 183: 2449-2458.
20. Martin, S., Kohler, H., Weltzien, H. U. and Leipner, C., Selective activation of CD8 T cell effector functions by epitope variants of lymphocytoic choriomeningitis virus glycoprotein. J. Immunol. 1996. 157: 2358-2365.
21. Bachmann, M. F., Sebzda, E., Kündig, T. M., Shahinian, A., Speiser, D., Mak, T. W. and Ohashi, P. S., T cell responses are governed by avidity and costimulatory thresholds. Eur. J. Immunol. 1996. 26: 2017-2022.
22. Bachmann, M. F., Oxenius, A., Speiser, D. E., Mariathasan, S., Hengartner, H., Zinkernagel, R. M. and Ohashi, P. S., Peptide induced TCR-down regulation on naive T cell predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 1997. 27: 2195-2203.
23. Jameson, S. C., Carbone, F. R. and Bevan, M. J., Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 1993. 177: 1541-1550.
24. Racioppi, L., Ronchese, F., Matis, L. A. and Germain, R. N., Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 1993. 177: 1047-1060.
25. DeMagistris, M., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F. C., Grey, H. M. and Sette, A., antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992. 68: 625-634.
26. + T cells. J. Exp. Med. 1997. 186: 757-766.
27. Lyons, D. S., Lieberman, S. A., Hampl, J., Boniface, J. J., Chien, Y., Berg, L. J. and Davis, M. M., A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996. 5: 53-61.
28. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
29. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G. and Grey, H. M., Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 1994. 12: 413-431.
30. Jameson, S. C. and Bevan, M. J., T cell receptor antagonists and partial agonists. Immunity 1995. 2: 1-11.
31. Valitutti, S., Müller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
32. Bachmann, M. F., Ohteki, T., Zakarian, A., McKall-Faienza, K., Kägi, D., Speiser, D. E. and Ohashi, P., Altered peptide ligands trigger perforin-rather than Fas-dependent cell lysis. J. Immunol. 1997. 159: 4165-4160.
33. Sebzda, E., Kündig, T. M., Thomson, C. T., Aoki, K., Mak, S. Y., Mayer, J. P., Zamborelli, T., Nathenson, S. G. and Ohashi, P. S., Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 1996. 183: 1093-1104.
34. Preckel, T., Grimm, R., Martin, S. and Weltzien, H. U., Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors [see comments]. J. Exp. Med. 1997. 185: 1803-1813.
35. Viola, A., Linkert, S. and Lanzavecchia, A., A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur. J. Immunol. 1997. 27: 3080-3083.
36. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
37. Alexander, J., Snoke, K., Ruppert, J., Sidney, J., Wall, M., Southwood, S., Oseroff, C., Arrhenius, T., Gaeta, F. C. G., Colon, S. M., Grey, H. M. and Sette, A., Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 1993. 150: 1-7.
38. Salzmann, M. and Bachmann, M. F., The role of T cell receptor dimerization in T cell antagonism and T cell specificity. Mol. Immunol. 1998. 53: 271-277.
39. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., De Carli, M., Fiaccadori, F. and Ferrari, C., Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells. Nature 1994. 369: 407-410.
40. Alexander, J., Snoke, K., Ruppert, J., Sidney, J., Wall, M., Southwood, S., Oseroff, C., Arrhenius, T., Gaeta, F. C. and Colon, S. M., Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 1993. 150: 1-7.
41. + T cells. J. Exp. Med. 1997. 185: 641-651.
42. Salio, M., Valitutti, S. and Lanzavecchia, A., Agonist-induced T cell receptor down-regulation: molecular requirements and dissociation from T cell activation. Eur. J. Immunol. 1997. 27: 1769-1773.
43. Janeway, C. A., Ligands for the T cell receptor: hard times for avidity models, Immunol. Today 1995. 16: 223-225.
44. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Koppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E. and McMichael, A. J., Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 1994. 369: 403-407.
45. Sewell, A. K., Harcourt, G. C., Goulder, P. J. R., Price, D. A. and Philipps, R. E., Antagonism of cytotoxic T-lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur. J. Immunol. 1997. 27: 2323-2329.
46. + thymocytes in vitro does no require dedicated antigen presenting cells. Eur. J. Immunol. 1993. 23: 669-674.
47. Bachmann, M. F., Evaluation of lymphocytic choriomeningitis virus-specific cytotoxic T cell responses. In Lefkowitz, I. (Ed.) Immunology Methods Manual, Academic Press, New York 1997, pp 1921-1933.
48. Blichfeldt, E., Munthe, L. A., Rotnes, J. S. and Bogen, B., Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor. Eur. J. Immunol. 1996. 26: 2876-2844.